The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...
As a kid, Ilya Finkelstein always wanted to be a scientist. Curious about the natural world, he found himself outside, ...
MUSC health has established the Rena N. Grant Sickle Cell Center to help treat those suffering from sickle cell disease. This ...
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...
An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.
The Mater Hospital has successfully treated the first patient in Ireland with a ground-breaking ocular gene therapy. The gene ...
The rise in CRISPR Therapeutics' share price can be attributed to the better-than-expected Q4 results and a rating upgrade by a well-established financial services firm.
Why did humans start speaking? Scientists suggest genetics played a big role. They say the evolution of this singular ability ...
How does the public feel about breakthrough technologies like AI, cell and gene therapy, cultivated meat, and new genomic techniques? 13,000 people weighed in worldwide.
The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...
A team of Bahraini specialists has successfully treated a patient with sickle cell disease using the revolutionary CRISPR gene-editing technology, making Bahrain the first country outside the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback